Eliseo Salinas, M.D., M.Sc.
Senior Vice President, Chief Scientific Officer and Head of External Innovation
Eliseo Salinas, M.D., M.Sc. is our Senior Vice President, Chief Scientific Officer and Head of External Innovation and has been at ACADIA since September 2018. Dr. Salinas brings 27 years of experience developing diverse therapeutic products for CNS and other disorders and has been directly involved with 16 IND submissions and 15 regulatory approvals. Prior to joining ACADIA, Dr. Salinas most recently served as Chief Medical Officer for New World Laboratories where he led pre-clinical, clinical and regulatory activities. Prior to joining New World Laboratories, Dr. Salinas served in leadership positions in R&D at several companies including as Executive Vice President, R&D and Chief Scientific Officer at Shire; Executive Vice President, Head of Development and Chief Medical Officer at Elan Pharmaceuticals; Vice President, Head of Worldwide CNS Product Development at Wyeth and Head of R&D at several small pharmaceutical and biotechnology companies. Dr. Salinas received his M.D. from the University of Buenos Aires, completed his residency in Psychiatry at the Clinique des Maladies Mentales et de l’Encéphale, Paris and obtained his Master’s degree in Pharmacology from the Université Pierre et Marie Curie, Academie de Paris.